Evaluating the Clinical Characteristics and Ophthalmic Manifestations in Children and Adolescents with Acquired Demyelinating Disorders in China
Pediatric acquired demyelinating disorders (ADS) include various monophasic and recurrent inflammatory conditions of the central nervous system (CNS). Optic neuritis (ON) is a demyelinating disease primarily affecting the optic nerve axons due to autoimmune inflammation. To investigate the clinical...
Saved in:
| Published in: | British journal of hospital medicine (London, England : 2005) Vol. 86; no. 3; p. 1 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
26.03.2025
|
| Subjects: | |
| ISSN: | 1750-8460 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Pediatric acquired demyelinating disorders (ADS) include various monophasic and recurrent inflammatory conditions of the central nervous system (CNS). Optic neuritis (ON) is a demyelinating disease primarily affecting the optic nerve axons due to autoimmune inflammation. To investigate the clinical characteristics, ophthalmic manifestations, laboratory test results, and prognostic indicators of Chinese children and adolescents with ADS.
The clinical data of 57 patients with ADS treated in the Beijing Children's Hospital from March 2021 to December 2023, were retrospectively collected and analyzed. The primary outcomes include best-corrected visual acuity (BCVA) at onset, peripapillary retinal nerve fiber layers (RNFL) thickness, serum myelin oligodendrocyte glycoprotein (MOG) antibody level, aquaporin-4 (AQP4) antibody level, and final BCVA after hormone therapy.
The analyses included 57 children and adolescents in the study, including 38 optic neuritis (ON), 12 neuromyelitis optica spectrum disorder (NMOSD), 5 acute disseminated encephalomyelitis (ADEM), and 2 multiple sclerosis (MS) patients. The median age of patients facing the initial attack of ON was 9 years (3-15 years), with 23 children and adolescents (40.4%) aged eight years or younger, and 37 patients (64.9%) were bilaterally affected. Half of the children and adolescents (15/30) were MOG-Ab seropositive, and 19.4% (6/31) were AQP4-Ab seropositive. Children and adolescents with NMOSD were more likely to have severe visual impairment at acute onset (
< 0.05), with 84.2% of them having low vision acuity (BCVA worse than 0.1), as compared with 64.9% in the ON group. The RNFL thickness of affected eye was thinner than unaffected eyes (median 72.0 μm vs. median 102.0 μm,
< 0.05). Patients with NMOSD exhibited lower RNFL thickness across all measured sectors compared to those with ON. Significant differences were noted in the average RNFL and in each specific region of the retina, including the temporal RNFL, nasal RNFL, nasal superior RNFL, nasal inferior RNFL, temporal superior RNFL, and temporal inferior RNFL (all
< 0.05). After the treatment with intravenous methylprednisolone, both patients with ON (52 eyes; 86.7%) or NMOSD (20 eyes; 90.9%) group had functional visual recovery (BCVA better or equal 0.4).
This study shows that Chinese children and adolescents with ADS present distinctive clinical features, including earlier onset and more bilateral involvement. Furthermore, NMOSD patients experience more severe visual acuity impairment and thinner peripapillary RNFL. All children and adolescents of ON or NMOSD respond well to methylprednisolone treatment. |
|---|---|
| AbstractList | Pediatric acquired demyelinating disorders (ADS) include various monophasic and recurrent inflammatory conditions of the central nervous system (CNS). Optic neuritis (ON) is a demyelinating disease primarily affecting the optic nerve axons due to autoimmune inflammation. To investigate the clinical characteristics, ophthalmic manifestations, laboratory test results, and prognostic indicators of Chinese children and adolescents with ADS.
The clinical data of 57 patients with ADS treated in the Beijing Children's Hospital from March 2021 to December 2023, were retrospectively collected and analyzed. The primary outcomes include best-corrected visual acuity (BCVA) at onset, peripapillary retinal nerve fiber layers (RNFL) thickness, serum myelin oligodendrocyte glycoprotein (MOG) antibody level, aquaporin-4 (AQP4) antibody level, and final BCVA after hormone therapy.
The analyses included 57 children and adolescents in the study, including 38 optic neuritis (ON), 12 neuromyelitis optica spectrum disorder (NMOSD), 5 acute disseminated encephalomyelitis (ADEM), and 2 multiple sclerosis (MS) patients. The median age of patients facing the initial attack of ON was 9 years (3-15 years), with 23 children and adolescents (40.4%) aged eight years or younger, and 37 patients (64.9%) were bilaterally affected. Half of the children and adolescents (15/30) were MOG-Ab seropositive, and 19.4% (6/31) were AQP4-Ab seropositive. Children and adolescents with NMOSD were more likely to have severe visual impairment at acute onset (
< 0.05), with 84.2% of them having low vision acuity (BCVA worse than 0.1), as compared with 64.9% in the ON group. The RNFL thickness of affected eye was thinner than unaffected eyes (median 72.0 μm vs. median 102.0 μm,
< 0.05). Patients with NMOSD exhibited lower RNFL thickness across all measured sectors compared to those with ON. Significant differences were noted in the average RNFL and in each specific region of the retina, including the temporal RNFL, nasal RNFL, nasal superior RNFL, nasal inferior RNFL, temporal superior RNFL, and temporal inferior RNFL (all
< 0.05). After the treatment with intravenous methylprednisolone, both patients with ON (52 eyes; 86.7%) or NMOSD (20 eyes; 90.9%) group had functional visual recovery (BCVA better or equal 0.4).
This study shows that Chinese children and adolescents with ADS present distinctive clinical features, including earlier onset and more bilateral involvement. Furthermore, NMOSD patients experience more severe visual acuity impairment and thinner peripapillary RNFL. All children and adolescents of ON or NMOSD respond well to methylprednisolone treatment. Aims/Background Pediatric acquired demyelinating disorders (ADS) include various monophasic and recurrent inflammatory conditions of the central nervous system (CNS). Optic neuritis (ON) is a demyelinating disease primarily affecting the optic nerve axons due to autoimmune inflammation. To investigate the clinical characteristics, ophthalmic manifestations, laboratory test results, and prognostic indicators of Chinese children and adolescents with ADS. Methods The clinical data of 57 patients with ADS treated in the Beijing Children's Hospital from March 2021 to December 2023, were retrospectively collected and analyzed. The primary outcomes include best-corrected visual acuity (BCVA) at onset, peripapillary retinal nerve fiber layers (RNFL) thickness, serum myelin oligodendrocyte glycoprotein (MOG) antibody level, aquaporin-4 (AQP4) antibody level, and final BCVA after hormone therapy. Results The analyses included 57 children and adolescents in the study, including 38 optic neuritis (ON), 12 neuromyelitis optica spectrum disorder (NMOSD), 5 acute disseminated encephalomyelitis (ADEM), and 2 multiple sclerosis (MS) patients. The median age of patients facing the initial attack of ON was 9 years (3-15 years), with 23 children and adolescents (40.4%) aged eight years or younger, and 37 patients (64.9%) were bilaterally affected. Half of the children and adolescents (15/30) were MOG-Ab seropositive, and 19.4% (6/31) were AQP4-Ab seropositive. Children and adolescents with NMOSD were more likely to have severe visual impairment at acute onset (p < 0.05), with 84.2% of them having low vision acuity (BCVA worse than 0.1), as compared with 64.9% in the ON group. The RNFL thickness of affected eye was thinner than unaffected eyes (median 72.0 μm vs. median 102.0 μm, p < 0.05). Patients with NMOSD exhibited lower RNFL thickness across all measured sectors compared to those with ON. Significant differences were noted in the average RNFL and in each specific region of the retina, including the temporal RNFL, nasal RNFL, nasal superior RNFL, nasal inferior RNFL, temporal superior RNFL, and temporal inferior RNFL (all p < 0.05). After the treatment with intravenous methylprednisolone, both patients with ON (52 eyes; 86.7%) or NMOSD (20 eyes; 90.9%) group had functional visual recovery (BCVA better or equal 0.4). Conclusion This study shows that Chinese children and adolescents with ADS present distinctive clinical features, including earlier onset and more bilateral involvement. Furthermore, NMOSD patients experience more severe visual acuity impairment and thinner peripapillary RNFL. All children and adolescents of ON or NMOSD respond well to methylprednisolone treatment.Aims/Background Pediatric acquired demyelinating disorders (ADS) include various monophasic and recurrent inflammatory conditions of the central nervous system (CNS). Optic neuritis (ON) is a demyelinating disease primarily affecting the optic nerve axons due to autoimmune inflammation. To investigate the clinical characteristics, ophthalmic manifestations, laboratory test results, and prognostic indicators of Chinese children and adolescents with ADS. Methods The clinical data of 57 patients with ADS treated in the Beijing Children's Hospital from March 2021 to December 2023, were retrospectively collected and analyzed. The primary outcomes include best-corrected visual acuity (BCVA) at onset, peripapillary retinal nerve fiber layers (RNFL) thickness, serum myelin oligodendrocyte glycoprotein (MOG) antibody level, aquaporin-4 (AQP4) antibody level, and final BCVA after hormone therapy. Results The analyses included 57 children and adolescents in the study, including 38 optic neuritis (ON), 12 neuromyelitis optica spectrum disorder (NMOSD), 5 acute disseminated encephalomyelitis (ADEM), and 2 multiple sclerosis (MS) patients. The median age of patients facing the initial attack of ON was 9 years (3-15 years), with 23 children and adolescents (40.4%) aged eight years or younger, and 37 patients (64.9%) were bilaterally affected. Half of the children and adolescents (15/30) were MOG-Ab seropositive, and 19.4% (6/31) were AQP4-Ab seropositive. Children and adolescents with NMOSD were more likely to have severe visual impairment at acute onset (p < 0.05), with 84.2% of them having low vision acuity (BCVA worse than 0.1), as compared with 64.9% in the ON group. The RNFL thickness of affected eye was thinner than unaffected eyes (median 72.0 μm vs. median 102.0 μm, p < 0.05). Patients with NMOSD exhibited lower RNFL thickness across all measured sectors compared to those with ON. Significant differences were noted in the average RNFL and in each specific region of the retina, including the temporal RNFL, nasal RNFL, nasal superior RNFL, nasal inferior RNFL, temporal superior RNFL, and temporal inferior RNFL (all p < 0.05). After the treatment with intravenous methylprednisolone, both patients with ON (52 eyes; 86.7%) or NMOSD (20 eyes; 90.9%) group had functional visual recovery (BCVA better or equal 0.4). Conclusion This study shows that Chinese children and adolescents with ADS present distinctive clinical features, including earlier onset and more bilateral involvement. Furthermore, NMOSD patients experience more severe visual acuity impairment and thinner peripapillary RNFL. All children and adolescents of ON or NMOSD respond well to methylprednisolone treatment. |
| Author | Shi, Wei Zuo, Hua-Xin Li, Li Lin, Qi Yu, Ji-Feng Peng, Chun-Xia Li, Si-Yuan Liu, Wen |
| Author_xml | – sequence: 1 givenname: Si-Yuan surname: Li fullname: Li, Si-Yuan organization: Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China – sequence: 2 givenname: Chun-Xia surname: Peng fullname: Peng, Chun-Xia organization: Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China – sequence: 3 givenname: Hua-Xin surname: Zuo fullname: Zuo, Hua-Xin organization: Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China – sequence: 4 givenname: Qi surname: Lin fullname: Lin, Qi organization: Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China – sequence: 5 givenname: Ji-Feng surname: Yu fullname: Yu, Ji-Feng organization: Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China – sequence: 6 givenname: Wen surname: Liu fullname: Liu, Wen organization: Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China – sequence: 7 givenname: Li surname: Li fullname: Li, Li organization: Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China – sequence: 8 givenname: Wei surname: Shi fullname: Shi, Wei organization: Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40135307$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kDtPwzAUhT0U0QfMbMgjS4od23mMVVoeUlEXmCPHdoiR47S2A-q_4Cdj0Xa6yznnu-fMwcQOVgFwh9ESp2VWPHa9kssUpXSJGGMTMMM5Q0lBMzQFc--_EGK0yNg1mFKECSMon4HfzTc3Iw_afsLQKVgZbbXgBlYdd1wE5bQPWnjIrYS7fRc6bnot4Bu3ulU-ROdgPdQ2GrSRTtl_5UoORnmhbPDwR4cOrsRh1E5JuFb9UUXICbnWfnBSuUuC5TfgquXGq9vzXYCPp8179ZJsd8-v1WqbiLSkIZEcFU3s2jCMGMclK5QiTUMy0gpEUpw1qMVCUl42jKW0wZhS2UoqRc4EzbN0AR5OuXs3HMbYpO51fNgYbtUw-prgApOsxJGxAPdn6djEieu90z13x_qyYvoHWMZ27g |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.12968/hmed.2024.0555 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| ExternalDocumentID | 40135307 |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- 0R~ 23N 36B 5GY 6PF AAFWJ AAMHT AAWTL ACGFS AENEX AFNVX AFWIA AJXAB ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF EBS ECM EIF EMB EMOBN F5P H13 HZ~ L.. MK0 NPM O9- RGK SJN SV3 7X8 |
| ID | FETCH-LOGICAL-c294t-da08b202b5105a1958ee3bb363fc03216b0f1cd4a9b5524b1144dfd4dc75c4762 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001469574500004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1750-8460 |
| IngestDate | Fri Sep 05 17:50:24 EDT 2025 Mon Jul 21 06:02:12 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | peripapillary retinal nerve fiber layers acquired demyelinating disorders multiple sclerosis neuromyelitis optica spectrum disorder acute disseminated encephalomyelitis myelin oligodendrocyte glycoprotein optic neuritis |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c294t-da08b202b5105a1958ee3bb363fc03216b0f1cd4a9b5524b1144dfd4dc75c4762 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 40135307 |
| PQID | 3181369120 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3181369120 pubmed_primary_40135307 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-03-26 |
| PublicationDateYYYYMMDD | 2025-03-26 |
| PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-26 day: 26 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | British journal of hospital medicine (London, England : 2005) |
| PublicationTitleAlternate | Br J Hosp Med (Lond) |
| PublicationYear | 2025 |
| SSID | ssj0054865 |
| Score | 2.3469262 |
| Snippet | Pediatric acquired demyelinating disorders (ADS) include various monophasic and recurrent inflammatory conditions of the central nervous system (CNS). Optic... Aims/Background Pediatric acquired demyelinating disorders (ADS) include various monophasic and recurrent inflammatory conditions of the central nervous system... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1 |
| SubjectTerms | Adolescent Aquaporin 4 - immunology Autoantibodies - blood Child Child, Preschool China - epidemiology Demyelinating Diseases Encephalomyelitis, Acute Disseminated Female Humans Male Multiple Sclerosis Myelin-Oligodendrocyte Glycoprotein - immunology Neuromyelitis Optica - diagnosis Optic Neuritis - diagnosis Optic Neuritis - drug therapy Optic Neuritis - epidemiology Optic Neuritis - physiopathology Retrospective Studies Visual Acuity |
| Title | Evaluating the Clinical Characteristics and Ophthalmic Manifestations in Children and Adolescents with Acquired Demyelinating Disorders in China |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40135307 https://www.proquest.com/docview/3181369120 |
| Volume | 86 |
| WOSCitedRecordID | wos001469574500004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELWAcuDCIrayyUhcTR3bSZoTqgoVl5YeQOqt8kortWkhBYm_4JMZJy4VByQkLjll03g882bxG4SuVJpksGsoUbFgREgId1ScOsJSyQ2NXRZJVw6bSHu95mCQ9UPCrQhtlUubWBpqM9M-R94A3Yt4kkWM3sxfiJ8a5aurYYTGOqpxgDJeq9PBdxUBwHg5ShI8JCXgZ2mg9mFZ0myMwNlAeMjEtae8-h1fln6ms_PfP9xF2wFh4lalEntozeb76PMusHrnzxggHw50oBPc_knYjGVu8MN8tBjJyXSscVf63peiqtcXeJzjdjj9Xd7ZWvFBYZ_RxS3tO4utwbd2-uGPulefXHJ8Lt-QywP01Ll7bN-TMIyBaJaJBTGSNhXIS3lEJj1FjbVcKZ5wpylnUaKoi7QRMlNxzISCOEsYZ4TRaawFmNxDtJHPcnuMsMy08WUF7pJUWIj_pKFcK9GMLIAHR-vocingISi7r2DI3M7eiuFKxHV0VK3ScF6xcgx9oBiDxTr5w9OnaIv5Ob6UE5acoZqDrW7P0aZ-X4yL14tSi-Da63e_ACHq1I4 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluating+the+Clinical+Characteristics+and+Ophthalmic+Manifestations+in+Children+and+Adolescents+with+Acquired+Demyelinating+Disorders+in+China&rft.jtitle=British+journal+of+hospital+medicine+%28London%2C+England+%3A+2005%29&rft.au=Li%2C+Si-Yuan&rft.au=Peng%2C+Chun-Xia&rft.au=Zuo%2C+Hua-Xin&rft.au=Lin%2C+Qi&rft.date=2025-03-26&rft.issn=1750-8460&rft.volume=86&rft.issue=3&rft.spage=1&rft_id=info:doi/10.12968%2Fhmed.2024.0555&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-8460&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-8460&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-8460&client=summon |